Planchard, David: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Évaluation de l’expression de PD-L1 en immunohistochimie : un biomarqueur émergent dans les carcinomes pulmonaires non à petites cellules

Adam, Julien, Planchard, David, Marabelle, Aurélien, Soria, Jean-Charles, Scoazec, Jean-Yves, Lantuéjoul, Sylvie

Journal:

Annales de Pathologie

Year:

2016

File:

PDF, 888 KB

2016

2

Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting ALK and ROS1 Fusion and Resistance Mutations in Patients With NonâSmall-Cell Lung Cancer

Mezquita, Laura, Swalduz, AurÃ©lie, Jovelet, CÃ©cile, Ortiz-Cuaran, Sandra, Howarth, Karen, Planchard, David, Avrillon, Virginie, Recondo, Gonzalo, Marteau, SolÃ¨ne, Benitez, Jose Carlos, De Kievit, F

Journal:

JCO Precision Oncology

Year:

2020

File:

PDF, 699 KB

2020

3

BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall

Leonetti, Alessandro, Facchinetti, Francesco, Rossi, Giulio, Minari, Roberta, Conti, Antonia, Friboulet, Luc, Tiseo, Marcello, Planchard, David

Journal:

Cancer Treatment Reviews

Year:

2018

Language:

english

File:

PDF, 1.33 MB

english, 2018

4

Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation

Auliac, Jean Bernard, Pérol, Maurice, Planchard, David, Monnet, Isabelle, Wislez, Marie, Doubre, Hélène, Guisier, Florian, Pichon, Eric, Greillier, Laurent, Mastroianni, Bénédicte, Decroisette, Chanta

Journal:

Year:

2018

Language:

english

File:

PDF, 409 KB

english, 2018

5

Identification of driver mutations in lung cancer: first step in personalized cancer

Planchard, David

Journal:

Targeted Oncology

Year:

2013

Language:

english

File:

PDF, 240 KB

english, 2013

6

Targeting ALK -rearranged non-small-cell lung cancer: an update

Sullivan, Ivana, Planchard, David

Journal:

Future Oncology

Year:

2017

Language:

english

File:

PDF, 1.94 MB

english, 2017

7

Long leptomeningeal responses with brigatinib in two heavily pre-treated ALK-rearranged non-small cell lung cancer patients

Geraud, Arthur, Mezquita, Laura, Bigot, Frederic, Caramella, Caroline, Planchard, David, Le Pechoux, Cecile, Besse, Benjamin

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 1.50 MB

english, 2018

8

10-year long-term survival of a metastatic EGFR -mutated nonsmall cell lung cancer patient: FIGURE 1

Kempf, Emmanuelle, Planchard, David, Le Chevalier, Thierry, Soria, Jean-Charles

Journal:

European Respiratory Journal

Year:

2015

Language:

english

File:

PDF, 243 KB

english, 2015

9

Autoimmune protein S activity deficiency following a Q fever

Boinot, Catherine, Planchard, David, Giraudeau, Geneviève, Turhan, Ali, Agius, Gérard, Guicheteau, Maryse

Journal:

Thrombosis and Haemostasis

Year:

2007

Language:

english

File:

PDF, 157 KB

english, 2007

10

Vascular Presentation and Outcomes of Patients With Giant Cell Arteritis and Isolated Symptomatic Limb Involvement

de Boysson, Hubert, Espitia, Olivier, Liozon, Eric, Daumas, Aurélie, Vautier, Mathieu, Dumont, Anael, Granel, Brigitte, Saadoun, David, Planchard, Gaétane, Ly, Kim Heang, Aouba, Achille

Journal:

JCR Journal of Clinical Rheumatology

Year:

2019

File:

PDF, 192 KB

2019

11

Liquid biopsies could be superior to tumor biopsy to provide a molecular profile in non-small cell lung cancer (NSCLC) patients

Remon, Jordi, Lacroix, Ludovic, Planchard, David, Pannet, Chloe, Jovelet, Cecile, Lawson, Andrew, Smalley, Sarah, Howarth, Kevin, Gale, David, Green, Emma, Plagnol, Vincent, Rosenfeld, Nicolas, Soria,

Journal:

Journal of Thoracic Oncology

Year:

2016

Language:

english

File:

PDF, 73 KB

english, 2016

12

P3.02c-065 Neutrophil-To-Lymphocyte and Other Ratios as Prognostic and Predictive Markers of Immune Checkpoint Inhibitors in Advanced NSCLC Patients

Mezquita, Laura, Charrier, Melinda, Auclin, Edouard, Gion, Maria, Remon, Jordi, Planchard, David, Dupraz, Louise, Lahmar, Jihene, Gazzah, Annas, Chaput, Nathalie, Besse, Benjamin

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 171 KB

english, 2017

13

BRAF Adds an Additional Piece of the Puzzle to Precision Oncology-Based Treatment Strategies in Lung Cancer

Planchard, David, Johnson, Bruce E.

Journal:

Archives of Pathology & Laboratory Medicine

Year:

2018

Language:

english

File:

PDF, 513 KB

english, 2018

14

The role of brigatinib in crizotinib-resistant non-small cell lung cancer

Mezquita, Laura, Planchard, David

Journal:

Cancer Management and Research

Year:

2018

Language:

english

File:

PDF, 161 KB

english, 2018

15

Bevacizumab in non-small-cell lung cancer: a review

Planchard, David

Journal:

Expert Review of Anticancer Therapy

Year:

2011

Language:

english

File:

PDF, 901 KB

english, 2011

16

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

Jänne, Pasi A., Yang, James Chih-Hsin, Kim, Dong-Wan, Planchard, David, Ohe, Yuichiro, Ramalingam, Suresh S., Ahn, Myung-Ju, Kim, Sang-We, Su, Wu-Chou, Horn, Leora, Haggstrom, Daniel, Felip, Enriqueta

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 563 KB

english, 2015

17

P1.07-012 Efficacy of Immune Checkpoint Inhibitors in Large Cell Neuroendocrine Lung Cancer: Results from a French Retrospective Cohort

Levra, Matteo Giaj, Mazieres, Julien, Valette, Clarisse Audigier, Molinier, Olivier, Planchard, David, Frappat, Violaine, Ferrer, Leonie, Toffart, Anne Claire, Moro-Sibilot, Denis

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 202 KB

english, 2017

18

P3.02c-066 HLA-A2 Status and Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

Mezquita, Laura, Charrier, Melinda, Auclin, Edouard, Dupraz, Louise, Remon, Jordi, Planchard, David, Gion, Maria, Lahmar, Jihene, Gazzah, Annas, Adam, Julien, Chaput, Nathalie, Besse, Benjamin

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 128 KB

english, 2017

19

Future Genetic/Genomic Biomarker Testing in Non–Small Cell Lung Cancer

Planchard, David, Remon, Jordi, Nowak, Frédérique, Soria, Jean-Charles

Journal:

American Society of Clinical Oncology Educational Book

Year:

2017

Language:

english

File:

PDF, 868 KB

english, 2017

20

A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study

Planchard, David, Yokoi, Takashi, McCleod, Michael J., Fischer, Jürgen R., Kim, Young-Chul, Ballas, Marc, Shi, Kelvin, Soria, Jean-Charles

Journal:

Clinical Lung Cancer

Year:

2016

Language:

english

File:

PDF, 898 KB

english, 2016

21

Safety of osimertinib in egfr -mutated non-small cell lung cancer

Mezquita, Laura, Varga, Andreea, Planchard, David

Journal:

Expert Opinion on Drug Safety

Year:

2018

Language:

english

File:

PDF, 1.05 MB

english, 2018

22

Editorial on the article entitled “brigatinib efficacy and safety in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in a phase I/II trial”

Sullivan, Ivana, Planchard, David

Journal:

Journal of Thoracic Disease

Year:

2016

Language:

english

File:

PDF, 185 KB

english, 2016

23

Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study

Atlan, Philippe, Bayar, Mohamed Amine, Lanoy, Emilie, Besse, Benjamin, Planchard, David, Ramon, Jordy, Raynard, Bruno, Antoun, Sami

Journal:

Supportive Care in Cancer

Year:

2017

Language:

english

File:

PDF, 673 KB

english, 2017

24

Dabrafenib plus trametinib in patients with previously untreated BRAF V600E -mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial

Planchard, David, Smit, Egbert F, Groen, Harry J M, Mazieres, Julien, Besse, Benjamin, Helland, Åslaug, Giannone, Vanessa, D'Amelio, Anthony M, Zhang, Pingkuan, Mookerjee, Bijoyesh, Johnson, Bruce E

Journal:

The Lancet Oncology

Year:

2017

Language:

english

File:

PDF, 923 KB

english, 2017

25

Durvalumab in non-small-cell lung cancer patients: current developments

Mezquita, Laura, Planchard, David

Journal:

Future Oncology

Year:

2017

Language:

english

File:

PDF, 1.10 MB

english, 2017

26

Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: a multicentric real-world study (BRIGALK study)

Descourt, Renaud, Perol, Maurice, Rousseau-Bussac, Gaëlle, Planchard, David, Mennecier, Bertrand, Wislez, Marie, Cortot, Alexis, Guisier, Florian, Galland, Loïck, Dô, Pascal, Schott, Roland, Dansin, E

Journal:

Year:

2019

Language:

english

File:

PDF, 2.24 MB

english, 2019

27

A Quality Control Data Acquisition System for a Mississippi River Water-Treatment Plant

Greenberg, David B., Planchard, Jerome A., Brodtmann, Noel V.

Journal:

Journal - American Water Works Association

Year:

1976

File:

PDF, 2.48 MB

1976

28

ACUTE TUBULAR NECROSIS DUE TO RHABDOMYOLYSIS RESULTING FROM INFLUENZA A INFECTION

Christine Pradère, David Planchard, Chloé Plouzeau, Isabelle Merlet-Chicoine, Simon Valéro, Marc Paccalin

Journal:

Journal of the American Geriatrics Society

Year:

2006

Language:

english

File:

PDF, 36 KB

english, 2006

29

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer

Besse, Benjamin, Planchard, David, Veillard, Anne-Sophie, Taillade, Laurent, Khayat, David, Ducourtieux, Muriel, Pignon, Jean-Pierre, Lumbroso, Jean, Lafontaine, Carole, Mathiot, Claire, Soria, Jean-C

Journal:

Year:

2012

Language:

english

File:

PDF, 263 KB

english, 2012

30

A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer

Scagliotti, Giorgio V., Germonpré, Paul, Bosquée, Leon, Vansteenkiste, Johan, Gervais, R., Planchard, David, Reck, Martin, De Marinis, Filippo, Lee, Jin Soo, Park, Keunchil, Biesma, Bonne, Gans, Steve

Journal:

Year:

2010

Language:

english

File:

PDF, 494 KB

english, 2010

31

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer

Mezquita, Laura, Auclin, Edouard, Ferrara, Roberto, Charrier, Melinda, Remon, Jordi, Planchard, David, Ponce, Santiago, Ares, Luis Paz, Leroy, Laura, Audigier-Valette, Clarisse, Felip, Enriqueta, Zeró

Journal:

Year:

2018

Language:

english

File:

PDF, 251 KB

english, 2018

32

Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer

Schernberg, Antoine, Mezquita, Laura, Boros, Angela, Botticella, Angela, Caramella, Caroline, Besse, Benjamin, Escande, Alexandre, Planchard, David, Le Péchoux, Cécile, Deutsch, Eric, Lee, Jung Weon

Journal:

Year:

2018

Language:

english

File:

PDF, 3.00 MB

english, 2018

33

Successful switch to vemurafenib plus cobimetinib after dabrafenib plus trametinib toxicity in BRAFV600E mutant metastatic non-small cell lung cancer

Chic, Nuria, Mezquita, Laura, Aldea, Mihaela, Chebib, Ralph, Caramella, Caroline, Planchard, David, Besse, Benjamin

Journal:

Clinical Lung Cancer

Year:

2020

File:

PDF, 6.31 MB

2020

34

FLAURA strikes again: efficacy of osimertinib is independent of PD-L1 expression

Abdayem, Pamela, Planchard, David

Journal:

Translational Lung Cancer Research

Year:

2020

File:

PDF, 230 KB

2020

35

Uncertain benefit from surgery in patients with lung metastases from breast carcinoma

David Planchard, Jean-Charles Soria, Stefan Michiels, Dominique Grunenwald, Pierre Validire, Raffaele Caliandro, Philippe Girard, Thierry Le Chevalier

Journal:

Year:

2004

Language:

english

File:

PDF, 107 KB

english, 2004

36

The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer

Ross, Kirsty, Pailler, Emma, Faugeroux, Vincent, Taylor, Melissa, Oulhen, Marianne, Auger, Nathalie, Planchard, David, Soria, Jean-Charles, Lindsay, Colin R., Besse, Benjamin, Vielh, Philippe, Farace,

Journal:

Expert Review of Molecular Diagnostics

Year:

2015

Language:

english

File:

PDF, 829 KB

english, 2015

37

Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma

Abedallaa, Nader, Tremblay, Lise, Baey, Charlotte, Fabre, Dominique, Planchard, David, Pignon, Jean Pierre, Guigay, Joel, Pechoux, Cécile Le, Soria, Jean Charles, de Montpreville, Vincent Thomas, Bess

Journal:

Journal of Thoracic Oncology

Year:

2012

Language:

english

File:

PDF, 259 KB

english, 2012

38

Crizotinib Primary Resistance Overcome by Ceritinib in a Patient with ALK-Rearranged Non-Small Cell Lung Cancer

Facchinetti, Francesco, Caramella, Caroline, Auger, Nathalie, Planchard, David, Adam, Julien, Lacroix, Ludovic, Remon, Jordi, Massard, Christophe, Soria, Jean-Charles, Friboulet, Luc, Besse, Benjamin

Journal:

Year:

2016

Language:

english

File:

PDF, 375 KB

english, 2016

39

Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC

Ramalingam, Suresh S., Vansteenkiste, Johan, Planchard, David, Cho, Byoung Chul, Gray, Jhanelle E., Ohe, Yuichiro, Zhou, Caicun, Reungwetwattana, Thanyanan, Cheng, Ying, Chewaskulyong, Busyamas, Shah,

Journal:

New England Journal of Medicine

Year:

2019

Language:

english

File:

PDF, 362 KB

english, 2019

40

Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for NonâSmall Cell Lung Cancer

Kas, Baptiste, Talbot, Hugues, Ferrara, Roberto, Richard, Colombe, Lamarque, Jean-Philippe, Pitre-Champagnat, StÃ©phanie, Planchard, David, Balleyguier, Corinne, Besse, Benjamin, Mezquita, Laura, Lass

Journal:

Year:

2020

File:

PDF, 366 KB

2020

41

Construction || A Quality Control Data Acquisition System for a Mississippi River Water-Treatment Plant

David B. Greenberg, Jerome A. Planchard and Noel V. Brodtmann

Journal:

American Water Works Association

Year:

1976

Language:

english

File:

PDF, 1.38 MB

english, 1976

42

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy

Recondo, Gonzalo, Mahjoubi, Linda, Maillard, Aline, Loriot, Yohann, Bigot, Ludovic, Facchinetti, Francesco, Bahleda, Rastislav, Gazzah, Anas, Hollebecque, Antoine, Mezquita, Laura, Planchard, David, N

Journal:

npj Precision Oncology

Year:

2020

File:

PDF, 1.28 MB

2020

43

Intervention in gastro-enteropancreatic neuroendocrine tumours

Baudin, Eric, Planchard, David, Scoazec, Jean-Yves, Guigay, Joël, Dromain, Clarisse, Hadoux, Julien, Debaere, Thierry, Elias, Dominique, Ducreux, Michel

Journal:

Best Practice & Research Clinical Gastroenterology

Year:

2012

Language:

english

File:

PDF, 216 KB

english, 2012

44

Inhibiteurs de ALK de 2e génération dans le cancer bronchique non à petites cellules : revue de la littérature

Viala, Marie, Brosseau, Solenn, Planchard, David, Besse, Benjamin, Soria, Jean-Charles

Journal:

Bulletin du Cancer

Year:

2015

File:

PDF, 859 KB

2015

45

Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

Planchard, David, Besse, Benjamin, Groen, Harry J M, Souquet, Pierre-Jean, Quoix, Elisabeth, Baik, Christina S, Barlesi, Fabrice, Kim, Tae Min, Mazieres, Julien, Novello, Silvia, Rigas, James R, Upala

Journal:

The Lancet Oncology

Year:

2016

Language:

english

File:

PDF, 470 KB

english, 2016

46

Durvalumab for the treatment of non-small cell lung cancer

Mezquita, Laura, Planchard, David

Journal:

Expert Review of Respiratory Medicine

Year:

2018

Language:

english

File:

PDF, 1.01 MB

english, 2018

47

Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience

Botticella, Angela, Mezquita, Laura, Le Pechoux, Cecile, Planchard, David

Journal:

Therapeutic Advances in Respiratory Disease

Year:

2019

Language:

english

File:

PDF, 279 KB

english, 2019

48

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Rizvi, Naiyer A, Mazières, Julien, Planchard, David, Stinchcombe, Thomas E, Dy, Grace K, Antonia, Scott J, Horn, Leora, Lena, Hervé, Minenza, Elisa, Mennecier, Bertrand, Otterson, Gregory A, Campos, L

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 364 KB

english, 2015

49

PROGNOSTIC VALUE OF HLA-A2 STATUS IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS

Mezquita, Laura, Charrier, Melinda, Faivre, Laura, Dupraz, Louise, Lueza, Béranger, Remon, Jordi, Planchard, David, Bluthgen, Maria Virginia, Facchinetti, Francesco, Rahal, Arslane, Polo, Valentina, G

Journal:

Year:

2017

Language:

english

File:

PDF, 378 KB

english, 2017

50

ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer

Passaro, Antonio, Addeo, Alfredo, Von Garnier, Christophe, Blackhall, Fiona, Planchard, David, Felip, Enriqueta, Dziadziuszko, Rafal, de Marinis, Filippo, Reck, Martin, Bouchaab, Hasna, Peters, Solang

Journal:

Year:

2020

File:

PDF, 369 KB

2020

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски